X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs NATCO PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH NATCO PHARMA STERLING BIOTECH/
NATCO PHARMA
 
P/E (TTM) x -1.8 30.7 - View Chart
P/BV x 0.1 23.2 0.3% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 STERLING BIOTECH   NATCO PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
NATCO PHARMA
Mar-14
STERLING BIOTECH/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs11877 1.2%   
Low Rs3424 0.8%   
Sales per share (Unadj.) Rs26.8223.4 12.0%  
Earnings per share (Unadj.) Rs-15.031.1 -48.1%  
Cash flow per share (Unadj.) Rs-5.540.3 -13.6%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs54.9219.5 25.0%  
Shares outstanding (eoy) m267.8733.07 810.0%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x0.32.9 8.9%   
Avg P/E ratio x-0.520.9 -2.2%  
P/CF ratio (eoy) x-1.316.1 -7.9%  
Price / Book Value ratio x0.13.0 4.3%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m1,86221,504 8.7%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5471,128 48.5%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,1817,389 97.2%  
Other income Rs m43167 25.5%   
Total revenues Rs m7,2237,556 95.6%   
Gross profit Rs m9471,793 52.8%  
Depreciation Rs m2,543304 835.5%   
Interest Rs m4,377366 1,195.3%   
Profit before tax Rs m-5,9311,290 -459.8%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924309 -623.4%   
Profit after tax Rs m-4,0071,027 -390.0%  
Gross profit margin %13.224.3 54.3%  
Effective tax rate %32.423.9 135.6%   
Net profit margin %-55.813.9 -401.3%  
BALANCE SHEET DATA
Current assets Rs m14,3353,681 389.4%   
Current liabilities Rs m49,8093,123 1,595.0%   
Net working cap to sales %-494.07.6 -6,535.2%  
Current ratio x0.31.2 24.4%  
Inventory Days Days40389 450.8%  
Debtors Days Days17159 290.8%  
Net fixed assets Rs m55,4327,685 721.3%   
Share capital Rs m268331 81.0%   
"Free" reserves Rs m13,9356,670 208.9%   
Net worth Rs m14,7017,259 202.5%   
Long term debt Rs m9,478955 992.5%   
Total assets Rs m73,98811,957 618.8%  
Interest coverage x-0.44.5 -7.8%   
Debt to equity ratio x0.60.1 490.1%  
Sales to assets ratio x0.10.6 15.7%   
Return on assets %0.511.7 4.3%  
Return on equity %-27.314.2 -192.5%  
Return on capital %-6.420.7 -31.0%  
Exports to sales %25.939.4 65.8%   
Imports to sales %0.25.7 3.0%   
Exports (fob) Rs m1,8602,908 64.0%   
Imports (cif) Rs m12421 2.9%   
Fx inflow Rs m1,8603,445 54.0%   
Fx outflow Rs m25703 3.5%   
Net fx Rs m1,8352,743 66.9%   
CASH FLOW
From Operations Rs m1,7191,440 119.3%  
From Investments Rs m-3,148-1,089 289.0%  
From Financial Activity Rs m1,426-353 -404.3%  
Net Cashflow Rs m-3-1 228.2%  

Share Holding

Indian Promoters % 33.9 52.0 65.1%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 9.9 16.6 59.5%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 26.0 151.2%  
Shareholders   21,482 25,395 84.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DISHMAN PHARMA  CADILA HEALTHCARE  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Jan 19, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS